Contact this trialFirst, we need to learn more about you.
Topoisomerase I inhibitor
PLX038 for Ovarian Cancer
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial tests PLX038, a drug that stops cancer cell growth, in patients with advanced ovarian, primary peritoneal, and fallopian tube cancers. The drug aims to shrink tumors by blocking enzymes needed for cancer cells to multiply.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service